Short answer
Vaxcyte, Inc. (PCVX) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders re-elected all three Class III directors through the 2029 annual meeting.
Vaxcyte, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholders re-elected all three Class III directors through the 2029 annual meeting
- Grant Pickering received strongest support, with 132,112,840 votes for and 901,240 withheld
- Deloitte & Touche LLP ratified as independent auditor with 137,230,032 votes for and 137,589 against
- Executive compensation approved on an advisory basis, with 130,011,017 votes for and 2,755,868 against
- Board continuity and auditor appointment reduce near-term governance uncertainty; compensation vote signals strong shareholder support
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Vaxcyte, Inc. 8-K filings
Get the next PCVX 8-K as it lands
Follow PCVX for push alerts, or ask the research agent what this filing means.